CAR Cell In Vitro Cytotoxicity Assay Service

Online Inquiry

The CAR Cell In Vitro Cytotoxicity Assay is a pivotal tool in assessing the efficacy and safety of CAR-T cell therapies. It plays a critical role in the preclinical evaluation of CAR-T constructs and the optimization of their functional characteristics. By simulating the In Vivo environment within an In Vitro setting, our service allows for a comprehensive evaluation of CAR-T cells, including their target-specific cytotoxicity, potency, and specificity.

Assay Overview

The cornerstone of the CAR Cell In Vitro Cytotoxicity assay lies in its ability to replicate the complex interplay between CAR-T cells and target cells, mimicking the tumor microenvironment. It involves co-culturing CAR-T cells with target cells expressing the relevant antigen. Creative Biolabs' expert team designs and customizes the assay to match the specific attributes of the CAR-T construct and the target antigen.

The assay measures cytotoxicity through various endpoints, including:

Cytokine Release: The production of cytokines, such as IFN-γ and IL-2, reflects the activation and effectiveness of CAR-T cells.
Target Cell Killing: The direct lysis of target cells by CAR-T cells provides a quantitative assessment of cytotoxicity.
Proliferation: Monitoring the expansion of CAR-T cells over time can provide insights into their persistence and long-term efficacy.

Assay Workflow

Our service follows a structured workflow to ensure a comprehensive assessment of CAR-T cells:

Fig.1 Assay Workflow. (Creative Biolabs Original)

Advantages of Our Service

High Sensitivity and Specificity
The CAR Cell In Vitro Cytotoxicity assay allows for the precise evaluation of CAR-T cell specificity and potency. It identifies even subtle differences in cytotoxicity, enabling the fine-tuning of CAR-T constructs.
Cost-Effective Preclinical Screening
Using this In Vitro assay can significantly reduce the cost and time associated with preclinical CAR-T cell therapy evaluation, making it an indispensable tool in the drug development process.
Customization for Diverse CAR-T Constructs
Creative Biolabs tailors the assay to accommodate different CAR-T constructs and target antigens, ensuring versatility and applicability across a wide range of research.
Reduction of In Vivo Testing
By providing a reliable and robust In Vitro alternative, our service minimizes the need for animal testing, aligning with ethical and regulatory standards.

For further information about our services, please reach out to us by email, and our dedicated team will promptly respond to your inquiries.

All products and services are For Research Use Only and CANNOT be used in the treatment or diagnosis of disease.

Key Updates

NEWSLETTER

The latest newsletter to introduce the latest breaking information, our site updates, field and other scientific news, important events, and insights from industry leaders

LEARN MORE NEWSLETTER

NEW SOLUTION

CellRapeutics™ In Vivo Cell Engineering: One-stop in vivo T/B/NK cell and macrophage engineering services covering vectors construction to function verification.

LEARN MORE SOLUTION

Novel Solution. (Creative Biolabs Authorized)

NOVEL TECHNOLOGY

Silence™ CAR-T Cell: A novel platform to enhance CAR-T cell immunotherapy by combining RNAi technology to suppress genes that may impede CAR functionality.

LEARN MORE NOVEL TECHNOLOGY

New Technology. (Creative Biolabs Authorized)

NEW SOLUTION

Canine CAR-T Therapy Development: From early target discovery, CAR design and construction, cell culture, and transfection, to in vitro and in vivo function validation.

LEARN MORE SOLUTION